Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

Evotec has announced that its subsidiary, Just – Evotec Biologics, has received a Gates Foundation grant with the goal of increasing worldwide access to biotherapeutics through its J.MD molecular design suite. Certain recipients of grants from the Gates Foundation have been encouraged to improve manufacture, and reduce cost, of monoclonal antibody drugs. The goal of […] The post Just – Evotec given Gates Foundation grant to increase global biotherapeutics access appeared first on Pharmafile.

Continue reading →